*January 2021* Jill Feldman, co-founder of the EGFR Resisters, presented on Diversifying Clinical Trial Inclusion Criteria: Currrent Challenges and Potential Solutions
*December 2019* Project PRIORITY (Patient Reported Initiative On Resistance, Incidence, Treatment studY), is a collaboration between LUNGevity Foundation and the EGFR
*November 2019* Jill Feldman, an EGFR Resisters co-founder was interviewed on the Today Show regarding Lung Cancer Awareness Month. Watch
*October 2019* Presented by EGFR Resisters Co-Founders. * Hospitalization - While TKIs are superior to other treatments for EGFR positive lung
If someone had told me when I was first diagnosed back in 2013 that I would be helping to drive
